DTRM Biopharma closes series A round

Zhejiang DTRM Biopharma Co. Ltd. (Zhejiang, China) raised a series A round on Jan. 2 worth more than $60 million, with components in two currencies. The round included a $45.9 million component led by Advantech Capital, and a RMB100 million ($15.3 million) investment from Green Pine Capital Partners in the form of an existing loan converted into equity...